Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

May 16, 2022

SELL
$5.92 - $9.98 $43.9 Million - $73.9 Million
-7,409,096 Reduced 36.12%
13,104,424 $89.4 Million
Q4 2021

Feb 14, 2022

BUY
$5.92 - $9.98 $121 Million - $205 Million
20,513,520 New
20,513,520 $140 Million

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Nextech Invest Ag Portfolio

Follow Nextech Invest Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nextech Invest Ag, based on Form 13F filings with the SEC.

News

Stay updated on Nextech Invest Ag with notifications on news.